Pharmaceuticals, Biotechnology and Life Sciences
Alternative to Emend® prevents nausea and vomiting associated with moderately and highly emetogenic chemotherapy in adult patients LAKE ZURICH, Ill.–(BUSINESS…
Funding and cooperation advances NovoNutrients’ piloting of its protein-making Carbon Capture and Utilization (CCU) technology to further energy sector sustainability…
TAMPA, Fla.–(BUSINESS WIRE)–#DCaaS–vXchnge, an award-winning data-center-as-a-service (DCaaS) provider, announced today that they have been awarded a multi-year contract to support…
STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that company executives will provide a corporate update at two upcoming investor…
BROOKLINE, Mass.–(BUSINESS WIRE)–Navigation Sciences™ will provide an update at the annual Medtech Strategist Innovation Summit San Francisco 2019 Conference on…
– Livoletide pivotal study in Prader-Willi syndrome (PWS) completed recruitment for patients ages 8 to 65 and is on track…
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Third paragraph, first sentence of release dated November 7, 2019, should read: Various auto-immune diseases —…
LA JOLLA, Calif.–(BUSINESS WIRE)–Avidity Biosciences, a biotechnology company pioneering Antibody-Oligonucleotide Conjugates (AOCs™) for the treatment of rare muscle disorders and…